Bausch + Lomb
Clinical trials sponsored by Bausch + Lomb, explained in plain language.
Bausch + Lomb
BLCO
NYSE
An eye health company selling contact lenses, pharmaceuticals, and surgical products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New eye drops for pain enter early safety testing Results expected Nov 2026 (estimated)
- New laser aims to sharpen vision for the farsighted Results expected Nov 2026 (estimated)
- New eye drops aim to ease pain after laser surgery Results expected Feb 2027 (estimated)
- Can a new eye drop fully clear dry eye redness? Results expected Feb 2027 (estimated)
- New laser aims to sharpen vision for mild nearsightedness Results expected Sep 2027 (estimated)